Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
This report aims to provide a comprehensive presentation of the global market for Idiopathic Gastroparesis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idiopathic Gastroparesis Drugs. This report contains market size and forecasts of Idiopathic Gastroparesis Drugs in global, including the following market information:
Global Idiopathic Gastroparesis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Idiopathic Gastroparesis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prokinetic Agents Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Idiopathic Gastroparesis Drugs include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm and Ani Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Idiopathic Gastroparesis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Idiopathic Gastroparesis Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Idiopathic Gastroparesis Drugs Market Segment Percentages, by Type, 2022 (%)
Prokinetic Agents
Antiemetic Agents
Others
Global Idiopathic Gastroparesis Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Idiopathic Gastroparesis Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Global Idiopathic Gastroparesis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Idiopathic Gastroparesis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Idiopathic Gastroparesis Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Idiopathic Gastroparesis Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Idiopathic Gastroparesis Drugs, market overview.
Chapter 2: Global Idiopathic Gastroparesis Drugs market size in revenue.
Chapter 3: Detailed analysis of Idiopathic Gastroparesis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Idiopathic Gastroparesis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Idiopathic Gastroparesis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Idiopathic Gastroparesis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Idiopathic Gastroparesis Drugs Overall Market Size
2.1 Global Idiopathic Gastroparesis Drugs Market Size: 2022 VS 2029
2.2 Global Idiopathic Gastroparesis Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Idiopathic Gastroparesis Drugs Players in Global Market
3.2 Top Global Idiopathic Gastroparesis Drugs Companies Ranked by Revenue
3.3 Global Idiopathic Gastroparesis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Idiopathic Gastroparesis Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Idiopathic Gastroparesis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Idiopathic Gastroparesis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Idiopathic Gastroparesis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Idiopathic Gastroparesis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Idiopathic Gastroparesis Drugs Market Size Markets, 2022 & 2029
4.1.2 Prokinetic Agents
4.1.3 Antiemetic Agents
4.1.4 Others
4.2 By Type - Global Idiopathic Gastroparesis Drugs Revenue & Forecasts
4.2.1 By Type - Global Idiopathic Gastroparesis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Idiopathic Gastroparesis Drugs Revenue, 2024-2029
4.2.3 By Type - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Idiopathic Gastroparesis Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Private Clinics
5.1.4 Drug Stores
5.1.5 E-Commerce
5.2 By Application - Global Idiopathic Gastroparesis Drugs Revenue & Forecasts
5.2.1 By Application - Global Idiopathic Gastroparesis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Idiopathic Gastroparesis Drugs Revenue, 2024-2029
5.2.3 By Application - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Idiopathic Gastroparesis Drugs Market Size, 2022 & 2029
6.2 By Region - Global Idiopathic Gastroparesis Drugs Revenue & Forecasts
6.2.1 By Region - Global Idiopathic Gastroparesis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Idiopathic Gastroparesis Drugs Revenue, 2024-2029
6.2.3 By Region - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Idiopathic Gastroparesis Drugs Revenue, 2018-2029
6.3.2 US Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.3.3 Canada Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.3.4 Mexico Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Idiopathic Gastroparesis Drugs Revenue, 2018-2029
6.4.2 Germany Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.4.3 France Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.4.4 U.K. Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.4.5 Italy Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.4.6 Russia Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.4.8 Benelux Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Idiopathic Gastroparesis Drugs Revenue, 2018-2029
6.5.2 China Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.5.3 Japan Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.5.4 South Korea Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.5.6 India Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Idiopathic Gastroparesis Drugs Revenue, 2018-2029
6.6.2 Brazil Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.6.3 Argentina Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Idiopathic Gastroparesis Drugs Revenue, 2018-2029
6.7.2 Turkey Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.7.3 Israel Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Idiopathic Gastroparesis Drugs Market Size, 2018-2029
6.7.5 UAE Idiopathic Gastroparesis Drugs Market Size, 2018-2029
7 Idiopathic Gastroparesis Drugs Companies Profiles
7.1 Sumitomo
7.1.1 Sumitomo Company Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Idiopathic Gastroparesis Drugs Major Product Offerings
7.1.4 Sumitomo Idiopathic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.1.5 Sumitomo Key News & Latest Developments
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Company Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Major Product Offerings
7.2.4 Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.2.5 Cadila Pharmaceuticals Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Idiopathic Gastroparesis Drugs Major Product Offerings
7.3.4 Sanofi Idiopathic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Teva
7.4.1 Teva Company Summary
7.4.2 Teva Business Overview
7.4.3 Teva Idiopathic Gastroparesis Drugs Major Product Offerings
7.4.4 Teva Idiopathic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.4.5 Teva Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Idiopathic Gastroparesis Drugs Major Product Offerings
7.5.4 Johnson & Johnson Idiopathic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Idiopathic Gastroparesis Drugs Major Product Offerings
7.6.4 Pfizer Idiopathic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Kyowa Kirin Pharmaceuticals
7.7.1 Kyowa Kirin Pharmaceuticals Company Summary
7.7.2 Kyowa Kirin Pharmaceuticals Business Overview
7.7.3 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Major Product Offerings
7.7.4 Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.7.5 Kyowa Kirin Pharmaceuticals Key News & Latest Developments
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Company Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Idiopathic Gastroparesis Drugs Major Product Offerings
7.8.4 Hanmi Pharm Idiopathic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.8.5 Hanmi Pharm Key News & Latest Developments
7.9 Ani Pharmaceuticals
7.9.1 Ani Pharmaceuticals Company Summary
7.9.2 Ani Pharmaceuticals Business Overview
7.9.3 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Major Product Offerings
7.9.4 Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.9.5 Ani Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Idiopathic Gastroparesis Drugs Market Opportunities & Trends in Global Market
Table 2. Idiopathic Gastroparesis Drugs Market Drivers in Global Market
Table 3. Idiopathic Gastroparesis Drugs Market Restraints in Global Market
Table 4. Key Players of Idiopathic Gastroparesis Drugs in Global Market
Table 5. Top Idiopathic Gastroparesis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Idiopathic Gastroparesis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Idiopathic Gastroparesis Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Idiopathic Gastroparesis Drugs Product Type
Table 9. List of Global Tier 1 Idiopathic Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Idiopathic Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Idiopathic Gastroparesis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Idiopathic Gastroparesis Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Idiopathic Gastroparesis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Idiopathic Gastroparesis Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Idiopathic Gastroparesis Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Idiopathic Gastroparesis Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Sumitomo Company Summary
Table 31. Sumitomo Idiopathic Gastroparesis Drugs Product Offerings
Table 32. Sumitomo Idiopathic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Sumitomo Key News & Latest Developments
Table 34. Cadila Pharmaceuticals Company Summary
Table 35. Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Product Offerings
Table 36. Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Cadila Pharmaceuticals Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Idiopathic Gastroparesis Drugs Product Offerings
Table 40. Sanofi Idiopathic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Teva Company Summary
Table 43. Teva Idiopathic Gastroparesis Drugs Product Offerings
Table 44. Teva Idiopathic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Teva Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Idiopathic Gastroparesis Drugs Product Offerings
Table 48. Johnson & Johnson Idiopathic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Idiopathic Gastroparesis Drugs Product Offerings
Table 52. Pfizer Idiopathic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Kyowa Kirin Pharmaceuticals Company Summary
Table 55. Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Product Offerings
Table 56. Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Kyowa Kirin Pharmaceuticals Key News & Latest Developments
Table 58. Hanmi Pharm Company Summary
Table 59. Hanmi Pharm Idiopathic Gastroparesis Drugs Product Offerings
Table 60. Hanmi Pharm Idiopathic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Hanmi Pharm Key News & Latest Developments
Table 62. Ani Pharmaceuticals Company Summary
Table 63. Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Product Offerings
Table 64. Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Ani Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Idiopathic Gastroparesis Drugs Segment by Type in 2022
Figure 2. Idiopathic Gastroparesis Drugs Segment by Application in 2022
Figure 3. Global Idiopathic Gastroparesis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Idiopathic Gastroparesis Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Idiopathic Gastroparesis Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Idiopathic Gastroparesis Drugs Revenue in 2022
Figure 8. By Type - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 16. US Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 28. China Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Idiopathic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Idiopathic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Sumitomo Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cadila Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Teva Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Kyowa Kirin Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hanmi Pharm Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ani Pharmaceuticals Idiopathic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
